a2-Levantanolide

2,3-di(hexadecanoyloxy)propyl 2-[2-[(1E,3E,5E,7E)-2,6-dimethyl-8-(2,6,6-trimethylcyclohexen-1-yl)octa-1,3,5,7-tetraenyl]-4-[(1E,3E,5E)-4-methyl-6-(2,6,6-trimethylcyclohexen-1-yl)hexa-1,3,5-trienyl]pyridin-1-ium-1-yl]ethyl phosphate

A2-Iso5-2DC18

A2-Iso5-4DC19

a-Levantanolide

Myxovirescin A2

Ephrin-A2-selective YSA-peptide

4-((Cyclohexylamino)methyl)benzoic acid hydrochloride

1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine

2-Methoxy-6-(pyrazol-1-yl)-benzonitrile

(2E,2'E)-Diethyl 3,3'-((phenylazanediyl)bis(4,1-phenylene))diacrylate

1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-

6-{Bicyclo[2.2.1]hept-5-en-2-yl}-3-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione

2-[(Diethylcarbamoyl)methyl]-2-fluoropropanedioic acid

(4-Methyl-tetrahydro-furan-2-yl)-methanol

N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide

4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde